Canada Life’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,890
| Closed | -$14K | – | 2165 |
|
|
2023
Q3 | $14K | Sell |
1,890
-33,346
| -95% | -$277K | ﹤0.01% | 2181 |
|
|
2023
Q2 | $367K | Sell |
35,236
-28,529
| -45% | -$275K | ﹤0.01% | 1753 |
|
|
2023
Q1 | $657K | Sell |
63,765
-1,125
| -2% | -$14.4K | ﹤0.01% | 1629 |
|
|
2022
Q4 | $896K | Buy |
64,890
+22,011
| +51% | +$306K | ﹤0.01% | 1559 |
|
|
2022
Q3 | $878K | Buy |
42,879
+4,705
| +12% | +$103K | ﹤0.01% | 1529 |
|
|
2022
Q2 | $739K | Buy |
38,174
+5,536
| +17% | +$113K | ﹤0.01% | 1582 |
|
|
2022
Q1 | $721K | Hold |
32,638
| – | – | ﹤0.01% | 1619 |
|
|
2021
Q4 | $899K | Hold |
32,638
| – | – | ﹤0.01% | 1557 |
|
|
2021
Q3 | $853K | Hold |
32,638
| – | – | ﹤0.01% | 1578 |
|
|
2021
Q2 | $885K | Sell |
32,638
-1,062
| -3% | -$25.9K | ﹤0.01% | 1574 |
|
|
2021
Q1 | $788K | Sell |
33,700
-4,510
| -12% | -$91.2K | ﹤0.01% | 1599 |
|
|
2020
Q4 | $586K | Sell |
38,210
-4,970
| -12% | -$63.1K | ﹤0.01% | 1708 |
|
|
2020
Q3 | $521K | Sell |
43,180
-2,589
| -6% | -$24.6K | ﹤0.01% | 1662 |
|
|
2020
Q2 | $464K | Sell |
45,769
-4,250
| -8% | -$43.8K | ﹤0.01% | 1711 |
|
|
2020
Q1 | $518K | Buy |
50,019
+4,520
| +10% | +$56.7K | ﹤0.01% | 1581 |
|
|
2019
Q4 | $721K | Buy |
+45,499
| New | +$695K | ﹤0.01% | 1611 |
|
|
2019
Q3 | – | Sell |
-51,827
| Closed | -$1.02M | – | 1176 |
|
|
2019
Q2 | $1.02M | Hold |
51,827
| – | – | ﹤0.01% | 1524 |
|
|
2019
Q1 | $1.18M | Buy |
51,827
+6,295
| +14% | +$137K | ﹤0.01% | 1328 |
|
|
2018
Q4 | $845K | Hold |
45,532
| – | – | ﹤0.01% | 1468 |
|
|
2018
Q3 | $989K | Hold |
45,532
| – | – | ﹤0.01% | 1528 |
|
|
2018
Q2 | $1.01M | Hold |
45,532
| – | – | ﹤0.01% | 1526 |
|
|
2018
Q1 | $785K | Sell |
45,532
-2,694
| -6% | -$44.9K | ﹤0.01% | 1597 |
|
|
2017
Q4 | $801K | Hold |
48,226
| – | – | ﹤0.01% | 1598 |
|
|
2017
Q3 | $785K | Hold |
48,226
| – | – | ﹤0.01% | 1596 |
|
|
2017
Q2 | $781K | Buy |
48,226
+4,737
| +11% | +$74.9K | ﹤0.01% | 1594 |
|
|
2017
Q1 | $754K | Buy |
43,489
+2,702
| +7% | +$45.2K | ﹤0.01% | 1596 |
|
|
2016
Q4 | $688K | Buy |
40,787
+3,474
| +9% | +$57.9K | ﹤0.01% | 1614 |
|
|
2016
Q3 | $654K | Buy |
37,313
+3,228
| +9% | +$52.4K | ﹤0.01% | 1598 |
|
|
2016
Q2 | $490K | Buy |
34,085
+31,244
| +1,100% | +$390K | ﹤0.01% | 1656 |
|
|
2016
Q1 | $35K | Hold |
2,841
| – | – | ﹤0.01% | 2243 |
|
|
2015
Q4 | $35K | Hold |
2,841
| – | – | ﹤0.01% | 2257 |
|
|
2015
Q3 | $38K | Hold |
2,841
| – | – | ﹤0.01% | 2185 |
|
|
2015
Q2 | $47K | Buy |
+2,841
| New | +$47.2K | ﹤0.01% | 2245 |
|
Other funds holding ANGO
SFM
Canada Life's ANGO Position: Q4 2023 in Review
Canada Life sold out of AngioDynamics (ANGO) in Q4 2023, closing a stake of 1,890 shares — an estimated $14K sold.
Canada Life first reported a position in ANGO in Q2 2015 and held it in 33 quarters. The position peaked at $1.18M in Q1 2019. 150 funds tracked by Wall St. Rank hold ANGO as of Q4 2023.
- Canada Life reported no remaining AngioDynamics position as of Q4 2023 after selling out during the quarter.
- Canada Life sold 1,890 AngioDynamics shares in Q4 2023, an estimated $14K.
- Canada Life first reported a position in AngioDynamics in Q2 2015 and held it in 33 quarters.
- Canada Life's AngioDynamics position peaked at $1.18M in Q1 2019.
- 150 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2023.
Based on Canada Life's 13F filing for Q4 2023, filed 13 Feb 2024.